Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease

Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease

Objectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuo Abe, Mayako Takanashi, Takehiko Yanagihara, Sabro Sakoda
Format: Article
Language:English
Published: Wiley 2002-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.1155/2002/473140
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items